Design considerations of an IL13Rα2 antibody–drug conjugate for diffuse intrinsic pontine glioma

Diffuse intrinsic pontine glioma (DIPG), a rare pediatric brain tumor, afflicts approximately 350 new patients each year in the United States. DIPG is noted for its lethality, as fewer than 1% of patients survive to five years. Multiple clinical trials involving chemotherapy, radiotherapy, and/or ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Xiaolei, Kats, Dina, Rasmussen, Samuel, Martin, Leah R., Karki, Anju, Keller, Charles, Berlow, Noah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127302/
https://www.ncbi.nlm.nih.gov/pubmed/34001278
http://dx.doi.org/10.1186/s40478-021-01184-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127302/
https://www.ncbi.nlm.nih.gov/pubmed/34001278
http://dx.doi.org/10.1186/s40478-021-01184-9

Ejemplares similares